(ESLT) Elbit Systems - Overview
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0010811243
Stock: Unmanned Aerial, Electro-Optic, C4ISR, Electronic Warfare, Armored Vehicles
Total Rating 60
Risk 81
Buy Signal -0.14
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.58% |
| Yield on Cost 5y | 1.97% |
| Yield CAGR 5y | 10.67% |
| Payout Consistency | 89.6% |
| Payout Ratio | 33.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.7% |
| Relative Tail Risk | -5.77% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.22 |
| Alpha | 107.57 |
| Character TTM | |
|---|---|
| Beta | 0.242 |
| Beta Downside | 0.213 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.43% |
| CAGR/Max DD | 2.87 |
Description: ESLT Elbit Systems December 17, 2025
Elbit Systems Ltd. (NASDAQ:ESLT) designs, manufactures, and integrates airborne, land, and naval defense solutions for a global customer base that includes the U.S. military, foreign military sales programs, homeland-security agencies, and commercial aviation operators.
The firm operates through five segments-Aerospace; C4I & Cyber; ISTAR & Electronic Warfare; Land; and Elbit Systems of America (ESA)-offering a breadth of products such as unmanned aerial systems, precision-guided-munition sensors, electro-optical lasers, cyber-intelligence platforms, and survivability kits for armored vehicles.
Key metrics from FY 2023 show revenue of roughly $5.9 billion, an operating margin near 9 %, and an order backlog exceeding $8.5 billion, reflecting strong demand driven by rising U.S. defense appropriations (≈4 % YoY growth) and Israel’s sustained defense-spending target of ~3 % of GDP. The global shift toward autonomous and network-centric warfare further underpins growth prospects for Elbit’s UAV and C4ISR portfolios.
For a deeper dive into valuation multiples and peer comparison, the ValueRay database offers a concise snapshot.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 463.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 4.17 > 1.0 |
| NWC/Revenue: 22.96% < 20% (prev 12.44%; Δ 10.51% < -1%) |
| CFO/TA 0.07 > 3% & CFO 913.1m > Net Income 463.6m |
| Net Debt (923.8m) to EBITDA (800.5m): 1.15 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.7m) vs 12m ago 6.84% < -2% |
| Gross Margin: 24.23% > 18% (prev 0.24%; Δ 2399 % > 0.5%) |
| Asset Turnover: 67.88% > 50% (prev 60.51%; Δ 7.37% > 0%) |
| Interest Coverage Ratio: 4.14 > 6 (EBITDA TTM 800.5m / Interest Expense TTM 151.7m) |
Altman Z'' 2.42
| A: 0.15 (Total Current Assets 7.42b - Total Current Liabilities 5.62b) / Total Assets 12.24b |
| B: 0.22 (Retained Earnings 2.74b / Total Assets 12.24b) |
| C: 0.05 (EBIT TTM 627.9m / Avg Total Assets 11.54b) |
| D: 0.34 (Book Value of Equity 2.82b / Total Liabilities 8.23b) |
| Altman-Z'' Score: 2.42 = A |
Beneish M -3.15
| DSRI: 0.77 (Receivables 3.14b/3.42b, Revenue 7.84b/6.56b) |
| GMI: 0.99 (GM 24.23% / 23.89%) |
| AQI: 0.96 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 1.19 (Revenue 7.84b / 6.56b) |
| TATA: -0.04 (NI 463.6m - CFO 913.1m) / TA 12.24b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of ESLT shares?
As of February 08, 2026, the stock is trading at USD 665.00 with a total of 151,835 shares traded.
Over the past week, the price has changed by -5.35%, over one month by +3.89%, over three months by +43.68% and over the past year by +118.80%.
Over the past week, the price has changed by -5.35%, over one month by +3.89%, over three months by +43.68% and over the past year by +118.80%.
Is ESLT a buy, sell or hold?
Elbit Systems has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold ESLT.
- StrongBuy: 0
- Buy: 0
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ESLT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 573.6 | -13.7% |
| Analysts Target Price | 573.6 | -13.7% |
| ValueRay Target Price | 1001.5 | 50.6% |
ESLT Fundamental Data Overview February 05, 2026
P/E Trailing = 73.0233
P/S = 4.3327
P/B = 8.1329
P/EG = 2.21
Revenue TTM = 7.84b USD
EBIT TTM = 627.9m USD
EBITDA TTM = 800.5m USD
Long Term Debt = 249.6m USD (from longTermDebt, last quarter)
Short Term Debt = 345.5m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 923.8m USD (from netDebt column, last quarter)
Enterprise Value = 33.78b USD (33.45b + Debt 1.07b - CCE 733.3m)
Interest Coverage Ratio = 4.14 (Ebit TTM 627.9m / Interest Expense TTM 151.7m)
EV/FCF = 45.86x (Enterprise Value 33.78b / FCF TTM 736.7m)
FCF Yield = 2.18% (FCF TTM 736.7m / Enterprise Value 33.78b)
FCF Margin = 9.40% (FCF TTM 736.7m / Revenue TTM 7.84b)
Net Margin = 5.92% (Net Income TTM 463.6m / Revenue TTM 7.84b)
Gross Margin = 24.23% ((Revenue TTM 7.84b - Cost of Revenue TTM 5.94b) / Revenue TTM)
Gross Margin QoQ = 24.89% (prev 23.97%)
Tobins Q-Ratio = 2.76 (Enterprise Value 33.78b / Total Assets 12.24b)
Interest Expense / Debt = 3.28% (Interest Expense 35.0m / Debt 1.07b)
Taxrate = 7.86% (11.6m / 147.2m)
NOPAT = 578.5m (EBIT 627.9m * (1 - 7.86%))
Current Ratio = 1.32 (Total Current Assets 7.42b / Total Current Liabilities 5.62b)
Debt / Equity = 0.27 (Debt 1.07b / totalStockholderEquity, last quarter 4.00b)
Debt / EBITDA = 1.15 (Net Debt 923.8m / EBITDA 800.5m)
Debt / FCF = 1.25 (Net Debt 923.8m / FCF TTM 736.7m)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 463.6m / Total Assets 12.24b)
RoE = 12.77% (Net Income TTM 463.6m / Total Stockholder Equity 3.63b)
RoCE = 16.18% (EBIT 627.9m / Capital Employed (Equity 3.63b + L.T.Debt 249.6m))
RoIC = 13.28% (NOPAT 578.5m / Invested Capital 4.36b)
WACC = 6.69% (E(33.45b)/V(34.52b) * Re(6.81%) + D(1.07b)/V(34.52b) * Rd(3.28%) * (1-Tc(0.08)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.35%
[DCF Debug] Terminal Value 76.59% ; FCFF base≈522.0m ; Y1≈342.7m ; Y5≈156.4m
Fair Price DCF = 66.34 (EV 4.01b - Net Debt 923.8m = Equity 3.08b / Shares 46.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 8.66 | EPS CAGR: -42.78% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.19 | Revenue CAGR: 7.35% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.00 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=13.80 | Chg30d=-0.117 | Revisions Net=-1 | Growth EPS=+13.0% | Growth Revenue=+11.4%
P/S = 4.3327
P/B = 8.1329
P/EG = 2.21
Revenue TTM = 7.84b USD
EBIT TTM = 627.9m USD
EBITDA TTM = 800.5m USD
Long Term Debt = 249.6m USD (from longTermDebt, last quarter)
Short Term Debt = 345.5m USD (from shortTermDebt, last quarter)
Debt = 1.07b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 923.8m USD (from netDebt column, last quarter)
Enterprise Value = 33.78b USD (33.45b + Debt 1.07b - CCE 733.3m)
Interest Coverage Ratio = 4.14 (Ebit TTM 627.9m / Interest Expense TTM 151.7m)
EV/FCF = 45.86x (Enterprise Value 33.78b / FCF TTM 736.7m)
FCF Yield = 2.18% (FCF TTM 736.7m / Enterprise Value 33.78b)
FCF Margin = 9.40% (FCF TTM 736.7m / Revenue TTM 7.84b)
Net Margin = 5.92% (Net Income TTM 463.6m / Revenue TTM 7.84b)
Gross Margin = 24.23% ((Revenue TTM 7.84b - Cost of Revenue TTM 5.94b) / Revenue TTM)
Gross Margin QoQ = 24.89% (prev 23.97%)
Tobins Q-Ratio = 2.76 (Enterprise Value 33.78b / Total Assets 12.24b)
Interest Expense / Debt = 3.28% (Interest Expense 35.0m / Debt 1.07b)
Taxrate = 7.86% (11.6m / 147.2m)
NOPAT = 578.5m (EBIT 627.9m * (1 - 7.86%))
Current Ratio = 1.32 (Total Current Assets 7.42b / Total Current Liabilities 5.62b)
Debt / Equity = 0.27 (Debt 1.07b / totalStockholderEquity, last quarter 4.00b)
Debt / EBITDA = 1.15 (Net Debt 923.8m / EBITDA 800.5m)
Debt / FCF = 1.25 (Net Debt 923.8m / FCF TTM 736.7m)
Total Stockholder Equity = 3.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.02% (Net Income 463.6m / Total Assets 12.24b)
RoE = 12.77% (Net Income TTM 463.6m / Total Stockholder Equity 3.63b)
RoCE = 16.18% (EBIT 627.9m / Capital Employed (Equity 3.63b + L.T.Debt 249.6m))
RoIC = 13.28% (NOPAT 578.5m / Invested Capital 4.36b)
WACC = 6.69% (E(33.45b)/V(34.52b) * Re(6.81%) + D(1.07b)/V(34.52b) * Rd(3.28%) * (1-Tc(0.08)))
Discount Rate = 6.81% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 3.35%
[DCF Debug] Terminal Value 76.59% ; FCFF base≈522.0m ; Y1≈342.7m ; Y5≈156.4m
Fair Price DCF = 66.34 (EV 4.01b - Net Debt 923.8m = Equity 3.08b / Shares 46.5m; r=6.69% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 8.66 | EPS CAGR: -42.78% | SUE: -4.0 | # QB: 0
Revenue Correlation: 88.19 | Revenue CAGR: 7.35% | SUE: -0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.00 | Chg30d=-0.005 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=13.80 | Chg30d=-0.117 | Revisions Net=-1 | Growth EPS=+13.0% | Growth Revenue=+11.4%